Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2008-01-10
Original market date: See footnote 1
1996-08-14
Product name:
LYPHOLYTE
DIN:
02139618 Electronic product monograph is not available
Company:
PHARMACEUTICAL PARTNERS OF CANADA INC
45 Vogell Road, Suite 200
Richmond Hill
Ontario
Canada
L4B 3P6
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
6
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XA30 COMBINATIONS OF ELECTROLYTES
Active ingredient group (AIG) number:See footnote5
0610335002
Active ingredient(s) | Strength |
---|---|
CALCIUM ACETATE | 440 MG / 20 ML |
MAGNESIUM ACETATE | 860 MG / 20 ML |
POTASSIUM ACETATE | 690 MG / 20 ML |
POTASSIUM CHLORIDE | 2.5 G / 20 ML |
SODIUM ACETATE | 2.7 G / 20 ML |
SODIUM GLUCONATE | 1.1 G / 20 ML |